/
Pharmaceutical preparations company · DE · FY ends Jun · Revenue $48M · -2.58% margin · $3M FCF
Operating margin is thin at 3.72%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 8.0%, steady but not accelerating.
Insufficient data to identify specific risks. Treat any missing metrics as a data gap, not a clean bill of health.
Profitability & Returns
Revenue (TTM)
$48M
▲ +8.0% YoY
Net Income (TTM)
-$2M
▲ +621.4% YoY
Op. Margin
-2.58%
▲ +3.2pp YoY
ROIC
-4.64%
▲ +6.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$3M
▲ +380.5% YoY
Op. Cash Flow (TTM)
$3M
▲ +119.0% YoY
Net Debt
-$3M
Net Cash Position
Cash & Equiv.
$6M
5Y CAGR: +0.6%
5Y CAGR: +10.7%
Continue Research